Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.26
+2.1%		$0.27
$0.22
▼
$2.10
$30.41M1.39683,793 shs322,293 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$3.53
-4.1%		$5.66
$3.49
▼
$212.10
$1.90M0.62165,503 shs59,696 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$0.80
-3.5%		$1.16
$0.34
▼
$1.65
$28.71M2.16352,435 shs1.08 million shs
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
$9.60
-1.2%		$11.03
$7.94
▼
$52.50
$7.90M0.7531,670 shs12,070 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
+2.12%-1.63%-3.63%-28.86%-82.55%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-4.08%-26.71%-43.28%-64.61%-95.58%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-3.48%-7.40%-11.28%-62.16%-32.33%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-1.23%+0.10%-13.75%-53.22%-77.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accuray Incorporated stock logo
ARAY
Accuray
$0.26
+2.1%		$0.27
$0.22
▼
$2.10
$30.41M1.39683,793 shs322,293 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$3.53
-4.1%		$5.66
$3.49
▼
$212.10
$1.90M0.62165,503 shs59,696 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$0.80
-3.5%		$1.16
$0.34
▼
$1.65
$28.71M2.16352,435 shs1.08 million shs
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
$9.60
-1.2%		$11.03
$7.94
▼
$52.50
$7.90M0.7531,670 shs12,070 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accuray Incorporated stock logo
ARAY
Accuray
+2.12%-1.63%-3.63%-28.86%-82.55%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-4.08%-26.71%-43.28%-64.61%-95.58%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-3.48%-7.40%-11.28%-62.16%-32.33%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-1.23%+0.10%-13.75%-53.22%-77.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accuray Incorporated stock logo
ARAY
Accuray
1.67
Reduce$2.00669.23% Upside
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
1.00
SellN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
1.00
SellN/AN/A
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest TRIB, GCTK, ARAY, and IINN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/20/2026
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/5/2026
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/4/2026
Accuray Incorporated stock logo
ARAY
Accuray
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/17/2026
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/8/2026
Accuray Incorporated stock logo
ARAY
Accuray
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accuray Incorporated stock logo
ARAY
Accuray
$401.95M0.08N/AN/A$0.35 per share0.74
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A($3.38) per shareN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$289K99.33N/AN/A$0.06 per share13.31
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
$43.79M0.18N/AN/A($601.80) per share-0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accuray Incorporated stock logo
ARAY
Accuray
-$49.19M-$0.40N/AN/AN/A-12.24%-97.85%-10.82%11/4/2026 (Estimated)
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$19.39M-$137.63N/AN/AN/AN/A-2,135.52%-290.22%N/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$13.22MN/AN/AN/AN/AN/AN/AN/AN/A
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-$37.38M-$44.26N/AN/AN/A-70.06%N/A-32.13%9/3/2026 (Estimated)

Latest TRIB, GCTK, ARAY, and IINN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q2 2026
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-$7.80N/AN/AN/A$10.31 millionN/A
8/19/2026Q4 2026
Accuray Incorporated stock logo
ARAY
Accuray
-$0.03-$0.02+$0.01-$0.02$105.30 million$100.92 million
6/16/2026Q1 2026
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-$9.30-$6.90+$2.40-$0.23$10.68 million$10.85 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Accuray Incorporated stock logo
ARAY
Accuray
3.51
1.50
0.74
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.08
0.46
0.46
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.08
1.56
1.30
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
N/A
0.22
0.09

Institutional Ownership

CompanyInstitutional Ownership
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
12.72%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
78.97%

Insider Ownership

CompanyInsider Ownership
Accuray Incorporated stock logo
ARAY
Accuray
2.40%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5.90%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
29.40%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
8.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,040119.44 million116.57 millionOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5515,000485,000Not Optionable
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2035.95 million25.38 millionNot Optionable
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
480813,000746,000Optionable

Recent News About These Companies

Trinity Issues Updates On Diagnostics Launch; Plans To Regain Nasdaq Compliance By Feb '27
August 31 at 1:04 PM  |  rttnews.comhttps://www.rttnews.com/3687120/trinity-issues-updates-on-diagnostics-launch-plans-to-regain-nasdaq-compliance-by-feb-27.aspx
Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
August 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/28/3352900/8624/en/trinity-biotech-provides-diagnostics-business-transformation-and-corporate-update.html
Trinity Biotech (TRIB) Expected to Post Earnings on Thursday
August 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30985256
Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure
August 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/ai/articles/trinity-biotech-trinovium-subsidiary-agrees-123000376.html
Trinity Biotech's Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346100/8624/en/trinity-biotech-s-trinovium-subsidiary-agrees-to-collaborate-with-echelon-data-centres-to-develop-advanced-liquid-cooling-solutions-for-ai-infrastructure.html
Trinity Biotech plc (TRIB) Stock: Jumps as Perceptive Advisors Backs $7M Investment and Nasdaq Compliance Is Restored
August 14, 2026  |  blockonomi.comhttps://blockonomi.com/trinity-biotech-plc-trib-stock-jumps-as-perceptive-advisors-backs-7m-investment-and-nasdaq-compliance-is-restored/
Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345391/8624/en/trinity-biotech-secures-additional-7-0-million-investment-from-perceptive-advisors-and-regains-compliance-with-nasdaq-minimum-bid-price-requirement.html
Cours Trinity Biotech plc
July 25, 2026  |  zonebourse.comZ
Trinity Biotech plc: Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
July 22, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69093739-trinity-biotech-plc-trinity-biotech-partners-with-latch-medical-to-advance-biosensor-guided-precision-drug-delivery-solutions-using-cgm-technology-399.htm
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331256/8624/en/trinity-biotech-partners-with-latch-medical-to-advance-biosensor-guided-precision-drug-delivery-solutions-using-cgm-technology.html
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331247/8624/en/trinity-biotech-plc-announces-plan-to-implement-ads-ratio-change.html
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
July 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/02/3321317/8624/en/new-trinity-biotech-clinical-trial-data-shows-its-cgm-technology-tackles-a-major-cgm-user-problem-by-going-beyond-glucose-only-monitoring.html
Trinity Biotech plc: Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
June 30, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68899909-trinity-biotech-plc-trinity-biotech-terminates-standby-equity-purchase-agreement-with-yorkville-399.htm
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
June 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/ai/articles/trinity-biotech-trinovium-secures-open-130000705.html
Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319743/8624/en/trinity-biotech-s-trinovium-secures-open-compute-project-membership-advancing-hyperscale-market-access-and-commercial-validation-for-ai-data-center-liquid-cooling.html
Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
June 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/29/3319248/8624/en/trinity-biotech-terminates-standby-equity-purchase-agreement-with-yorkville.html
Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/23/3315854/8624/en/trinity-biotech-launches-trinovium-to-bring-healthcare-grade-fluid-technology-to-the-rapidly-growing-multi-billion-dollar-ai-data-center-liquid-cooling-market.html
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312709/8624/en/trinity-biotech-awarded-significant-orders-for-over-2-million-trinscreen-hiv-tests-and-reports-q1-2026-financial-results.html
Trinity Biotech Launches New $4.35 Million ATM Program with Lucid, Ends Craig-Hallum Mandate
June 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/trinity-biotech-launches-new-4-35-million-atm-program-with-lucid-ends-craig-hallum-mandate?utm_source=marketbeat.com&utm_medium=referral
Trinity Biotech Secures Interest Capitalization and Covenant Waiver From Perceptive
June 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/trinity-biotech-secures-interest-capitalization-and-covenant-waiver-from-perceptive?utm_source=marketbeat.com&utm_medium=referral

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Cardinal Health branded boxes on pallets sit amid automated conveyor systems in a distribution warehouse.
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
By Chris Markoch | August 12, 2026
Metal Apple logo displayed on a pedestal inside a glass-walled Apple Store with trees and wooden fixtures.
Is Apple’s AI Strategy Smarter Than Skeptics Think?
By Sam Quirke | August 19, 2026
Accuray stock logo

Accuray NASDAQ:ARAY

$0.26 +0.01 (+2.12%)
Closing price 09/2/2026 04:00 PM Eastern
Extended Trading
$0.26 -0.01 (-1.92%)
As of 06:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$3.53 -0.15 (-4.08%)
Closing price 09/2/2026 04:00 PM Eastern
Extended Trading
$3.66 +0.13 (+3.54%)
As of 05:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$0.80 -0.03 (-3.48%)
As of 09/1/2026

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Trinity Biotech stock logo

Trinity Biotech NASDAQ:TRIB

$9.60 -0.12 (-1.23%)
Closing price 09/2/2026 03:59 PM Eastern
Extended Trading
$9.59 -0.01 (-0.10%)
As of 09/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas